Skip to main content Accessibility help
×
Home

Bipolar Disorder: A National Health Concern

  • Roger S. McIntyre and Jakub Z. Konarski

Abstract

Bipolar disorders are prevalent, disabling, and costly diseases that often pursue an inexorable course. Underdetection, misdiagnosis, and diagnostic delay frequently and unnecessarily interfere with appropriate treatment of the disorder. Mortality studies in bipolar disorder underscore the relevance of both unnatural and natural causes of death, inviting the need for improved preventative and primary health care for bipolar patients. The treatment framework for bipolar disorder must recognize and anticipate the multidirnensionality and comorbidity of this illness. Pharmacotherapy is necessary, with multiple concomitant medications required for most patients, In addition, adjunctive psychosocial interventions offer enhanced compliance and may beneficially influence psychopathological and functional outcomes. This article emphasizes the public health concern of bipolr disorder, and provides tactics to enhance detection of cryptic bipolar states, underscore the clinical and pathophysiological relevance of comorbidity in bipolar disorder, and provide a framework for multimodality therapy for this condition.

Copyright

Corresponding author

University Health Network, Edith Cavell Wing 3D-003, 399 Bathurst St, M5T 2S8, Ontario, Canada; Tel: 416-603-5279; Fax: 416-603-5368; E-mail: rmcintyr@uhnres.utoronto.ca.

References

Hide All
1.Angst, F, Stassen, HH, Clayton, PJ, Angst, J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167181.
2.Osby, U, Brandt, L, Correia, N, Ekbom, A, Sparen, P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844850.
3.Sharma, R, Markar, HR. Mortality in affective disorder. J Affect Disord. 1994;31(2):9196.
4.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press Inc.; 1994.
5.Weissman, MM, Bland, RC, Canino, GJ, et al.Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293299.
6.Judd, LL, Akiskal, HS, Schettler, PJ, et al.Prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261269.
7.Ghaemi, SN, Ko, JY, Goodwin, FK. “Cade's disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002;47(2):125134.
8.Akiskal, HS, Bourgeois, ML, Angst, J, Post, R, Moller, H, Hirschfeld, R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(Suppl 1):S5S30.
9.Perris, C. The course of depressive psychoses. Acta Psychiatr Scand. 1968;44(3):238248.
10.Dunner, DL, Fleiss, JL, Fieve, RR. The course of development of mania in patients with recurrent depression. Am J Psychiatry. 1976;133(8):905908.
11.Strober, M, Carlson, G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry. 1982;39(5):549555.
12.Angst, J. Switch from depression to mania--a record study over decades between 1920 and 1982. Psychopathology. 1985;18(2-3):140154.
13.Geller, B, Fox, LW, Clark, KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry. 1994;33(4):461468.
14.Rao, U, Ryan, ND, Birmaher, B, et al.Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry. 1995;34(5):566578.
15.Kovacs, M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry. 1996;35(6):705715.
16.Goldberg, JF, Harrow, M, Whiteside, JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. 2001;158(8): 12651270.
17.Angst, J, Merikangas, K. The depressive spectrum: diagnostic classification and course. J Affect Disord. 1997;45(1-2):3139.
18.Regier, DA, Boyd, JH, Burke, JD, et al.One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988;45(11):977986.
19.Kessler, RC, McGonagle, KA, Zhao, S, et al.Lifetime and 12-month prevalence of DSM-III-R psychiatic disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:819.
20.Lewinsohn, PM, Klein, DN, Seeley, JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34(4):454463.
21.Szadoczky, E, Papp, Z, Vitrai, J, Rihmer, Z, Furedi, J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord. 1998;50(2-3):153162.
22.Angst, j. The emerging epidemiolgoy of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143151.
23.Judd, LL, Akiskal, HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003;73(1-2):123131.
24.Hirschfeld, RMA, Williams, JB, Spitzer, RL, et al.Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000; 157(11): 18731875.
25.Judd, LL, Schettler, PJ, Akiskal, HS, et al.Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmocol. 2003;6(2):127137.
26.Chen, YW, Dilsaver, SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol Psychiatry. 1996;39(10):896899.
27.Kessler, RC, Borges, G, Walters, EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617626.
28.Tondo, L, Isacsson, G, Baldessarini, R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17(7):491511.
29.Leverich, GS, Altshuler, LL, Frye, MA, et al.Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry. 2003;64(5):506515.
30.Begley, CE, Annegers, JF, Swann, AC, et al.The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001;19(5 Ptl):483495.
31.McIntyte, RS, Konarski, JZ, Yatham, LN. Comorbidity in bipolar disorder: a framework for rational treatment selection. Hum Psychophormacol. 2O04;19(6):369386.
32.McElroy, SL, Altshuler, LL, Suppes, T, et al.Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420426.
33.Nutt, DJ, Ballenger, JC, Sheehan, D, Wittchen, HU. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmocol. 2002;5(4):315325.
34.Kessler, R. Comorbidity of unipolar and bipolar depression with othet psychiatric disorders in a general population survey. In: Tohen, M, ed. Comorbidity in Affective Disorders. New York, NY: Marcel Dekker Inc.; 1999:125.
35.Chen, YW, Dilsaver, SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area survey. Am J Psychiatry. 1995;152(2):280282.
36.Goodwin, RD, Hoven, CW. Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. J Affect Disord. 2002;70(1):2733.
37.Birmaher, B, Kennah, A, Brent, D, Ehmann, M, Bridge, J, Axelson, D. Is bipolar disorder specifically associated with panic disorder in youths? J Clin Psychiatry. 2002;63:414419.
38.Dilsaver, SC, Chen, YW, Swann, AC, et al.Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res. 1997;73(1-2):4756.
39.Pini, S, Cassano, GB, Simonini, E, Savino, M, Russo, A, Montgomery, SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord. 1997;42(2-3):145153.
40.Frank, E, Cyranowski, JM, Rucci, P, et al.Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59(10):905911.
41.Savino, M, Perugi, G, Simonini, E, et al.Affective comorbidity in panic disorder: Is there a bipolar connection? J Affect Disord. 1993;28(3):155-63.
42.Bowen, R, South, M, Hawkes, J. Mood swings in patients with panic disorder. Can J Psychiatry. 1994;39(2):9194.
43.Grunhaus, L, Pande, AC, Brown, MB, Greden, JF. Clinical characteristics of patients wth concurrent majot depressive disorder and panic disorder. Am J Psychiatry. 1994;151(4):541546.
44.Biederman, J, Faraone, SV, Marrs, A, et al.Panic disorder and agoraphobia in consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36(2):214223.
45.MacKinnon, DF, Xu, J, McMahon, FJ, et al.Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry. 1998;155(6):829-31.
46.MacKinnon, DF, Zandi, PP, Gershon, E, et al.Rapid Switching of Mood in Families With Multiple Cases of Bipolar Disorder. Arch Gen Psychiatry. 2003;60(9):921928.
47.Rotondo, A, Mazzanti, C, Dell'Osso, L, et al.Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comotbid panic disorder. Am J Psychiatry. 2002;159(1):2329.
48.Wozniak, J, Biederman, J, Monuteaux, MC, Richards, J, Faraone, SV. Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J Child Adolesc Psychopharmacol. 2002;12(2): 101111.
49.MacKinnon, DF, Zandi, PP, Cooper, J, et al.Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002;159(1):3035.
50.Tohen, M, Greenfield, SF, Weiss, RD, et al.The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv Rev Psychiatry. 1998;6(3):133141.
51.Sonne, SC, Brady, KT. Substance abuse and bipolar comorbidity. Psychiatr Clin North Am. 1999;22(3):609627.
52.Cassidy, F, Aheam, EP, Carroll, BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3(4):181188.
53.Keck, PE Jr, McElroy, SL, Sttakowski, SM, et al.12-Month outcome of patients with bipolat disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998;155(5):646652.
54.Kruger, S, Shugar, G, Cooke, RG. Comorbidity of binge eating disorder and the partial binge eating syndtome with bipolar disorder. Int J Eat Disord. 1996;19(1):4552.
55.Lilliker, SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry. 1980;21(4):270275.
56.Cassidy, F, Ahearn, E, Carroll, BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156(9):14171420.
57.Regenold, WT, Thapar, RK, Marano, C, et al.Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002;70(1):1926.
58.Ruzickova, M, Slaney, C, Garnham, J, Aida, M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry. 2003;48(7):458461.
59.Weeke, A, Juel, K, Vaeth, M. Cardiovascular death and manic-depressive psychosis. J Affect Disord. 1987;13(3):287292.
60.Harris, EC, Barraclough, B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173:1153.
61.Fagioltni, A, Frank, E, Houck, PR, et al.Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry. 2002;63(6):528533.
62.McElroy, SL, Frye, MA, Suppes, T, et al.Correlates of ovetweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63(3):207213.
63.Fagiolini, A, Kupfer, DJ, Houck, PR, Novick, DM, Frank, E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003; 160(1):112117.
64.Sachs, G, Printz, D, Kahn, D, Catpenter, D, Docherty, J. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. Postgrad Med. 2000;1:1104.
65.Zarate, CA, Tohen, M. Bipolar disorder and comorbid axis I disorders: diagnosis and management. In: Yatham, LN, Kusumakar, V, Kutchet, SP. Treatment of Bipolar Disorder: A Clinicians Guide to Biological Treatments. New York, NY: Brunner Routledge; 2002;115138.
66.Figueroa, M, Gehlsen, J, Hammond, D, et al.Combination chemotherapy in refractory immune thrombocytopenic purpura. N Eng J Med. 1993;328(17):12261229.
67.Myers, LW, Phillips, JT. Polypharmacy in multiple sclerosis. Epilepsy Res. 1996;11(Suppl):181195.
68.Carpenter, CC, Fischl, MA, Hammer, SM, et al.Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA Panel. JAMA. 1997;277(24):19621969.
69.Konig, W, Rissom, R, Kalfoglu, G, Stein, A, Reimer, F. Long-term thetapy of affective disorders: monotherapy or polypharmacy? Pharmacopsychiatry. 1988;21(6):272273.
70.Rosholm, JU, Hallas, J, Gram, LF. Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients-a prescription database study. Br J Clin Pharmacol. 1994;37(6):533538.
71.Nichol, MB, Stimmel, GL, Lange, SC. Factors predicting the use of multiple psychotropic medications. J Clin Psychiatry. 1995;56(2):6066.
72.Frye, MA, Ketter, TA, Leverich, GS, et al.The increasing use of polypharma-cotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000;61(1):915.
73.Kupfer, DJ, Frank, E, Grochocinski, VJ, et al.Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63(2):120125.
74.Centorrino, F, Goren, JL, Hennen, J, et al.Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004;161(4):700706.
75.Morselli, PL, Elgie, R. GAMIAN-europe/BEAM survey I-global analysis of a patient questionnaire circulated to 3450 members of 12 european advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003;5(4):265278.
76.McIntyre, RS, Mancini, DA, Lin, P, Jordan, J. Treating bipolar disorder, evidence-based guidelines for family medicine. Can Fam Physician. 2004;50:388394.
77.American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (Revision). Am J Psychiatry. 2002;159(4 Suppl):150.

Related content

Powered by UNSILO

Bipolar Disorder: A National Health Concern

  • Roger S. McIntyre and Jakub Z. Konarski

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.